Page 1,930«..1020..1,9291,9301,9311,932..1,9401,950..»

Johns Hopkins Medicine, Maryland Stem Cell Research Fund and … – Business Wire (press release)

Posted: Published on March 1st, 2017

SAN CARLOS, Calif. & BALTIMORE--(BUSINESS WIRE)--Johns Hopkins Medicine, the Maryland Stem Cell Research Fund (MSCRF) and BioCardia, Inc. (OTC:BCDA) today announced that the first patient has been treated in the pivotal Phase III CardiAMP clinical trial of a cell-based therapy for the treatment of ischemic heart failure that develops after a heart attack. The first patient was treated at Johns Hopkins Hospital by a team led by Peter Johnston, MD, a faculty member in the Department of Medicine and Division of Cardiology, and principal investigator of the trial at Johns Hopkins. The investigational CardiAMP therapy is designed to deliver a high dose of a patients own bone marrow cells directly to the point of cardiac dysfunction, potentially stimulating the bodys natural healing mechanism after a heart attack. The patient experience with CardiAMP therapy begins with a pre-procedural cell potency screening test. If a patient qualifies for therapy, they are scheduled for a bone marrow aspiration. A point of care cell processing platform is then utilized to concentrate the autologous bone marrow cells, which are subsequently delivered in a minimally-invasive procedure directly to the damaged regions in a patients heart. This cell-based therapy offers great potential for heart failure patients, said … Continue reading

Posted in Stem Cell Research | Comments Off on Johns Hopkins Medicine, Maryland Stem Cell Research Fund and … – Business Wire (press release)

Stem cell treatment changed the life of one guest at Trump’s speech – CNN

Posted: Published on March 1st, 2017

She credits an experimental stem cell treatment with giving her new hope for her health and her future -- a newfound hope that also caught attention of Republican Rep. Pete Olson. "She is the face of the 21st Century Cures Act because of what she's gone through in her life," he said Tuesday. "It became pretty clear to me that ... I (have) got to tell her story," he said. "That's why she's here: She's awesome." Immediately after the House vote, Hughes said, Olson called her at home to invite her to be his guest of honor. "I still cannot believe I will be in the same room as our President and lawmakers," she added. Hughes spent most of her adolescence hospitalized, as she became so sick that she could barely walk and suffered immense pain. Her body was evaluated, treated and studied at the National Institutes of Health in collaboration with her doctors from the University of Texas Health Science Center at Houston. Yet relief came in 2014, when Hughes received a high-dose adult stem cell treatment that was not approved in the United States. For the procedure, Hughes had her own healthy stem cells cultured at the FDA-registered … Continue reading

Posted in Stem Cell Research | Comments Off on Stem cell treatment changed the life of one guest at Trump’s speech – CNN

Cerebral organoids enter the fold – Nature.com

Posted: Published on March 1st, 2017

Cerebral organoids enter the fold Nature.com Organoids are stem-cell-derived, three-dimensional cultures that self organize to some extent and include multiple cell types and features of a particular organ. Kriegstein, with Marina Bershteyn, Tomas Nowakowski and their colleagues, generated ... Excerpt from: Cerebral organoids enter the fold - Nature.com … Continue reading

Posted in Stem Cell Research | Comments Off on Cerebral organoids enter the fold – Nature.com

Canadian Pacific makes a $1 million gift to fund stem cell research at the CHU Sainte-Justine – New hope for … – Canada NewsWire (press release)

Posted: Published on March 1st, 2017

From left to right: Dr. Fabrice Brunet, The Honorable Michael M Fortier, Mr. Keith Creel, President and CEO of Canadian Pacific, Dr. Gregor Andelfinger, Ms. Maud Cohen, Ms. Janice Pierson, Mr. Richard Lanoue, Mher Mike Stepanian, Samuel Gauthier, Mariama Hawa Barry, Samy Touati, Tyler Lanoue and Olivier Boissonneault. (CNW Group/CHU Sainte-Justine Foundation) MONTRAL, Feb. 27, 2017 /CNW Telbec/ -An extraordinary $1 million commitment from Canadian Pacific (CP) towards stem cell research will allow the CHU Sainte-Justine to lead the way in developing new treatments to transform the lives of children suffering from complex congenital heart defects. Currently, there is no treatment available to provide a permanent means of repairing the heart. Today, patients and cardiac experts gathered to recognize the major impact of such strong support for research at the CHU Sainte-Justine, as well as the national importance of research in the development of innovative new stem cell technologies. Thanks to this exceptional gift, CP is making possible the creation of Quebec's first platform for stem cell research and pediatric regenerative medicine. "These funds will allow us to purchase new equipment and recruit an additional researcher, which will significantly accelerate essential research, namely the identification of the mechanisms that form … Continue reading

Posted in Stem Cell Research | Comments Off on Canadian Pacific makes a $1 million gift to fund stem cell research at the CHU Sainte-Justine – New hope for … – Canada NewsWire (press release)

Journal of the American College of Cardiology Recommends Olive Oil – Olive Oil Times

Posted: Published on March 1st, 2017

A new analysis of nutrition studies voices support for olive oil as a heart-healthy substitute for butter, while urging consumers to avoid coconut and palm oils. A group of doctors and researchers in the U.S. set out to examine the evidence behind a slew of claims, fads, diets and trends related to cardiovascular health. They published their findings in the latest issue of the Journal of the American College of Cardiology. Chief among the findings is that oils such as olive and canola are healthier than hard fats like butter and margarine. Extra virgin olive oil is singled out in the analysis as being the smartest heart-healthy choice, given the evidence accumulated in a large number of studies conducted on the food. The evidence base for olive oil is the most comprehensive, with clear evidence for a benet in cardiovascular risk reduction, the scientists said. At the same time, the researchers suggest that weight-conscious consumers might want to use olive oil only in moderation, given that it is high in calories. Coconut and palm oils, by contrast, come in for special concern. The analysis says the purported heart-health benefits of such oils are unsubstantiated and recommends that consumers avoid using … Continue reading

Posted in Cardiology | Comments Off on Journal of the American College of Cardiology Recommends Olive Oil – Olive Oil Times

Cardiologist named fellow of American College of Cardiology – Journal Gazette and Times-Courier

Posted: Published on March 1st, 2017

MATTOON -- Prairie Heart Institute of Illinois Cardiologist Michael LaMonto, DO, has been elected as a Fellow of the American College of Cardiology (FACC) in recognition of his professional achievement and commitment to quality cardiovascular care. Dr. LaMonto is part of the Prairie Heart Institute team of cardiology experts who provides care at Sarah Bush Lincoln. He holds six board certifications including general cardiology, echocardiography, nuclear cardiology, internal medicine, emergency medicine, and aerospace medicine. He works with fellow Prairie Heart Institute cardiologists Thomas Cahill, MD, and Amit Dande, MD, FACC, FSCAI and Physician Assistant Allyson Gough, PA-C, to evaluate and treat people with issues ranging from coronary artery disease to rhythm disorders and valve disease. Sarah Bush Lincoln President and CEO Jerry Esker, RPh, said, Dr. LaMonto has been a part of our communitys care team for many years and in different capacities, each time providing excellent medical care to people who seek care here. We couldnt be more pleased that he has achieved this designation in cardiology care because of the positive impact it will have on the cardiac needs of our community members. The FACC designation has a long history of recognizing the top cardiovascular professionals in the … Continue reading

Posted in Cardiology | Comments Off on Cardiologist named fellow of American College of Cardiology – Journal Gazette and Times-Courier

A Cardiologist Explains Which Health Food Fads Are Actually Good for You – Fortune

Posted: Published on March 1st, 2017

Fat was the enemy until it was rather abruptly usurped by sugar . Now nuts and whole-milk dairy products are making a comeback, while artificial sweeteners and sugar-laced low-fat snacks and drinks are viewed with a sudden suspicion. If youre experiencing whiplash, youre not alone. There is widespread chaos in the world of nutrition, says Andrew Freeman, the director of cardiovascular prevention and wellness at National Jewish Health in Denver. It seems recommendations swing back and forth all the time. In part, this is because nutrition is a slow and constantly evolving science. Well-designed studies, which ideally include a long duration time, a large sample size, and require participants to stick to a strict diet, are difficult and time-consuming to execute. This lack of clarity is exacerbated by the media, who thrive on highlighting the radical and new at the expense of more nuanced and gradual shifts, and Big Food, which works to influence the language used in federal recommendations and frequently takes advantage of consumer confusion to push new products. Take cholesterol. The latest dietary guidelines from the United States Department of Agriculture, released in 2015, removed the 300-milligram daily limit on cholesterol. Many media outlets jumped on the … Continue reading

Posted in Cardiology | Comments Off on A Cardiologist Explains Which Health Food Fads Are Actually Good for You – Fortune

Conversations in Cardiology: For Fellows, How Much Structural Heart Disease Training Is Enough? – TCTMD

Posted: Published on March 1st, 2017

Morton Kern, MD, of VA Long Beach Healthcare System and University of California, Irvine, often engages his colleagues via email in brief, informal dialogue on clinically relevant topics in interventional cardiology. With permission from the participants, TCTMD presents their conversations for the benefit of the interventional cardiology community. Your feedback is welcomefeel free to comment at the bottom of the page. Kirk Garrett, MD (Christiana Care Health System, Newark, DE), asks: I have a question for the group: Im currently have a job opening for an interventionalist. Many of the applicants are fellows graduating this summer who claim to bring structural skills, but many will have had just 1 year of interventional cardiology training. I maintain that competency in structural heart procedures requires a dedicated year, in addition to a year of coronary/peripheral training, and so have not been interviewing these folks. However, the volume of applicants with this background makes me wonder if community standards are changing. Am I being too stern on this? Have others had good experiences with trainees who come out of a 1 year training experience with adequate skills in both structural and routine interventional procedures? Jeffrey W. Moses, MD (Columbia University Medical Center, New … Continue reading

Posted in Cardiology | Comments Off on Conversations in Cardiology: For Fellows, How Much Structural Heart Disease Training Is Enough? – TCTMD

Prevencio, Inc. Data Published in Journal of the American College of … – Business Wire (press release)

Posted: Published on March 1st, 2017

KIRKLAND, Wash.--(BUSINESS WIRE)--Prevencio, Inc. today announces the publication of data that demonstrates that a simple blood test is substantially more accurate in diagnosis of heart disease than standard diagnostic methods, delivering results in only two hours. Researchers believe the data, published in Journal of the American College of Cardiology (JACC), could lead to improved diagnosis of obstructive coronary artery disease (CAD), lower disease and death rates, and lower healthcare costs. In the study, Prevencio researchers and Massachusetts General Hospital developed a clinical and multi-protein blood test, HARTTM CAD, to diagnose a patients likelihood of having clinically significant obstruction of the coronary arteries which could require invasive intervention to possibly prevent a heart attack or death. Lead author and Principal Investigator James L. Januzzi, MD, is a practicing cardiologist at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School. Januzzi and a team of researchers tested more than 900 subjects for the presence of obstruction of 70 percent or more in at least one major coronary artery the threshold for medical intervention. A positive result with the new diagnostic test indicated the presence of significant coronary obstruction 90 percent of the time, and also predicted risk of future heart … Continue reading

Posted in Cardiology | Comments Off on Prevencio, Inc. Data Published in Journal of the American College of … – Business Wire (press release)

Pfizer commits $4M to NC Biotechnology Center gene therapy fellowship program – WRAL Tech Wire

Posted: Published on March 1st, 2017

Posted Feb. 28, 2017 at 3:39 p.m. Published: 2017-02-28 15:39:55 Updated: 2017-02-28 15:39:55 By JIM SHAMP, NCBiotech Writer Raleigh, N.C. The North Carolina Biotechnology Center has announced that Pfizer has committed to providing funding in the amount of $4 million which will enable the Center to establish and administer a multi-year academic fellowship program to help advance North Carolinas fast-growing expertise in gene therapy. The new program, to be managed by NCBiotech, will support distinguished postdoctoral fellowships in North Carolina university research laboratories providing advanced scientific training in gene therapy-related research. Absent or faulty proteins linked to genetic mutations cause numerous devastating diseases, making gene therapy an increasingly important treatment strategy. Pfizers portfolio in North Carolina has grown in recent years. The company already operates a pharmaceutical manufacturing facility in the Lee County community of Sanford, and in August 2016, it acquired leading-edge gene therapy company Bamboo Therapeutics, Inc. in Chapel Hill. With that acquisition, Pfizer gained the expertise of Bamboos world-renowned co-founder, R. Jude Samulski, Ph.D., director of the Gene Therapy Centerat the University of North Carolina at Chapel Hill. The deal also included an 11,000-square-foot facility for the highly specialized manufacturing of recombinant adeno-associated viral vectors. Pfizer is … Continue reading

Posted in Biotechnology | Comments Off on Pfizer commits $4M to NC Biotechnology Center gene therapy fellowship program – WRAL Tech Wire

Page 1,930«..1020..1,9291,9301,9311,932..1,9401,950..»